Author: devcuration

Medical imaging is the heavyweight champ of healthcare data. Over 80% of it lives in pixels, scans, slices, and signals, yet most of the industry still treats it like loose film reels stacked in a forgotten basement. Flywheel shows up and says no, this data deserves infrastructure, discipline, and systems built for adults in the room. The market agreed with a $25M oversubscribed equity round led by Novalis LifeSciences and 8VC, backed by a lineup that reads less like hype and more like proof: NVentures at NVIDIA, Microsoft, Novartis, Intuitive Surgical, Hewlett Packard Enterprise, Beringea, Great North Ventures, iSelect, Gundersen…

Sirion just inked a deal that reads less like a funding announcement and more like a thesis on where enterprisesoftware is finally growing up. A majority investment from Haveli Investments, valuing Sirion at roughly $1B. Not hype math. Grown-up math. The kind that only shows up after a decade of building, breaking, fixing, and scaling inside the parts of the enterprise most people pretend are “handled.” Contracts rarely are. Ajay Agrawal did not wake up one morning chasing AI headlines. Ajay Agrawal lived inside the mess at UnitedLex and saw contracts treated like static PDFs instead of economic engines. Sirion…

January 8, 2026 did not read like a victory lap. It read like alignment. Protege secured a $30M Series A extension led by Andreessen Horowitz, bringing total capital raised to $65M since launching in 2024. No theatrics. No chest pounding. Just capital moving toward infrastructure that has already proven it belongs in the center of the AI economy. Protege operates where the real friction lives. Data that is regulated, licensed, governed, and actually usable. The kind of data that trains models without blowing up reputations or compliance teams. Headquartered in New York City, the company was founded by Bobby Samuels,…

Diagonal Therapeutics just closed an oversubscribed $125M Series B, and this is not one of those biotech headlines floating on vibes, deck aesthetics, and hope. This is what happens when computation, biology, and restraint stop posturing and start agreeing. Watertown, Massachusetts keeps proving that the loudest breakthroughs rarely raise their voice. They just show the data and wait. Founded in 2022 by Alexey Lugovskoy, Ph.D., alongside Atlas Venture, Diagonal Therapeutics emerged from stealth in April 2024 with a $128M Series A and a very specific opinion about signaling. Most antibodies shut things down. Diagonal activates, clusters, and restores. Digital. Agonist.…

The electrical grid is having its Don Draper moment, minus the whiskey and taglines. Instead it is choking on interconnection queues, capital constraints, and physics that do not care about quarterly narratives. That is the backdrop for encoord securing a $2M seed round led by KittyHawk Frontier, announced January 7, 2026, and quietly loud enough to matter. encoord did not appear because “energy transition” became fashionable. The roots of SAInt go back to 2013, when integrated planning was still treated like an academic exercise instead of an industry survival skill. The company itself was founded in 2019 by Dr. Carlo…

Money hates friction. It gets loud when invoices linger, reminders feel personal, and accounting systems act like payments are a rumor. That tension is exactly where Biller Genie walked in, calm and unapologetic, asking why accounts receivable still looks like unpaid overtime in a cloud-first economy. Orlando-built with a global stare, Biller Genie just closed $22M in Series B funding led by Radian Capital, and this raise feels earned, not announced. The story starts with Thomas Aronica seeing the mess up close while running SkyBank Financial. SMBs were working harder to get paid than to do the work itself. So…

AI agent acquisition is no longer theoretical. Meta Platforms, Inc., the company behind Facebook, Instagram, and WhatsApp, just made its most literal move in AI yet, acquiring Manus, the Singapore-based developer of a general AI agent built to turn thoughts into actions, in a deal reportedly valued at $2.5 billion. This was not a talent grab or a research flex. This was Meta buying execution. Manus is named for “hand,” and Meta did not buy a mouth. It bought something that actually does the work. Manus emerged from Butterfly Effect, founded in 2022, after the team proved they could scale…

January 5 did not read like a hiring post. It read like a pressure release. Goodword Inc., Brooklyn-born and barely a year old, announced team expansion less than three months after a $4M seed round and public launch. This wasn’t a vanity hire cycle or a speculative build. It was startup hiring momentum, the kind that shows up when usage is real, feedback has landed, and a company decides to lean into what’s already working. Goodword calls itself a networking copilot, but that label is polite. The product is built for people drowning in contacts and starving for context. 500…

Unconventional AI did not arrive quietly. It showed up with a question most of the industry stopped asking somewhere between CUDA kernels and thermal throttling alerts. What if the computer itself is wrong. Not slow. Not overpriced. Wrong for the job we keep forcing it to do. On the a16z Show, Naveen Rao walked straight into that question with the calm of someone who has already sold two answers for nine figures and still thinks the room is far too comfortable. Naveen Rao is not selling a chip. He is challenging an 80 yr abstraction. Digital machines were built for…

January 7, 2026 did not arrive with fireworks, but it landed with weight. IMVARIA out of Berkeley just secured strategic investment led by InHealth Ventures, joined by Labcorp Venture Fund and returning partner Cedar Crest Holdings. No headline number, no victory lap. Just capital that knows when to speak softly and move precisely, especially in medicine where volume rarely equals value. IMVARIA lives in the uncomfortable middle where lung disease hides. Late diagnoses. Invasive biopsies. Too many maybes and not enough time. Founded in 2019 by Dr. Joshua Reicher and Dr. Michael Muelly, both Stanford-trained physicians with Google reps and…